isabelobrien, Author at European Medical Journal - Page 47 of 66

Moderna joins BIA as 500th member

Moderna has joined the UK’s BioIndustry Association (BIA), taking the trade association’s membership to over 500 companies.

Roundtable: a discussion on the pandemic and gender parity

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

A roundtable on clinical trial transformation

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

Roundtable: the evolving landscape of patient advocacy

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.

GSK and Microsoft tackle Nepal disease transmission

A new disease surveillance project to curb the spread of known and unknown pathogens, especially mosquito-borne illnesses, has been launched by GSK and Microsoft in Nepal.

The leap from medicine to medical affairs

What is it like to switch from medicine to MA, and are we about to see this spike in the wake of COVID-19?

Elevating pharma’s parental leave policies

With continued drive for equality across the pharma industry, the issue of parental leave is coming to the fore. But is the industry’s approach sufficiently transparent, and what more can be done?

First malaria vaccine granted WHO prequalification

The World Health Organization (WHO) has granted the first prequalification for a malaria vaccine to GSK’s Mosquirix in an important step toward immunising children against the disease.

Driving post-conference motivation in pharma: a how-to guide

How can pharma embrace post-conference momentum?

The emergence of digital twins

What is a digital twin and how do they benefit pharma?